The Louisiana Cancer Research Center (LCRC) has extended the deadline for applications to its Cancer Research Training and Education Coordination Travel Awards Program to Friday, August 9, 2024.

CRTEC Travel Awards support student & trainee travel to professional conferences from July 1 - December 31, 2024.

This funding opportunity will provide awards up to a maximum of $2,500 to undergraduate students, graduate students, and postdoctoral trainees to enhance their cancer research training experience in LCRC-affiliated laboratories and to reinforce national exposure of LCRC research projects.

Please note:



• The trainee's Principal Investigator must be an LCRC member.
• Applicants must be presenting a poster or giving a platform presentation at the conference they are attending with the travel support funding.
• Trainees can apply for the award even if their travel has already occurred in July/August 2024.

For those who have already submitted an application that needs additional information, this time can be used to review the application and submit the missing documentation.   

Read the full funding announcement & application instructions here.

Principal Investigators, please make your trainees aware of this funding opportunity. Funding could be used to attend local, national or international conferences.

For additional information on eligibility and requirements, please visit the LCRC website:

https://www.louisianacancercenter.org/research/funding-opportunities

DELTA INNOVATOR SEARCH SEEKING NEW IDEAS TO IMPROVE HEALTH, ECONOMY IN REGION

Researchers, students, entrepreneurs, and innovators with ideas for advancing the health and economy of the Delta region of Arkansas, Mississippi, and Louisiana are encouraged to enter the inaugural Delta Innovator Search.

Projects should align with at least one of three target categories:

Scientific or Technical Innovations

Economic or Financial Innovations

Community Impact 2040 

Applicant Eligibility

Individuals, nonprofits, small businesses, entrepreneurs, students, faculty, cooperatives, teams, or other groups and entities with new ideas or solutions that could make the Delta a healthier, economically thriving region are encouraged to apply.

Applicants must be at least 18 years old and residents of Arkansas, Mississippi, or Louisiana OR demonstrate authentic partnership with an organization from the area that serves residents.

Deadline to Apply: July 30, 2024

American Society of Hematology (ASH) Annual Meeting - ABSTRACT SUBMISSION DEADLINE

This is a reminder that the abstract submission deadline for the ASH Annual Meeting, taking place December 7 - 10, 2024, in San Diego is Thursday, August 1.

For more information and key dates for ASH 2024, click HERE.

To register for this workshop, please click here.

CDMRP / FY24 Kidney Cancer Research Program

SYNOPSIS OF FY24 KCRP AWARD MECHANISMS

CDMRP / FY24 Prostate Cancer Research Program

SYNOPSIS OF FY24 PCRP AWARD MECHANISMS

CDMRP / FY24 Melanoma Research Program

SYNOPSIS OF FY24 MRP AWARD MECHANISMS

CDMRP / FY24 Pancreatic Cancer Research Program

SYNOPSIS OF FY24 PCARP AWARD MECHANISMS

CDMRP / FY24 Rare Cancers Research Program

SYNOPSIS OF FY24 RCRP AWARD MECHANISMS

CDMRP / FY24 Breast Cancer Research Program

SYNOPSIS OF FY24 BCRP AWARD MECHANISMS

CDMRP / FY24 Lung Cancer Research Program

SYNOPSIS OF FY24 LCRP AWARD MECHANISMS

CDMRP / FY24 Ovarian Cancer Research Program

SYNOPSIS OF FY24 OCRP AWARD MECHANISMS

CDMRP / FY24 Peer-Reviewed Medical Research Program

SYNOPSIS OF FY24 PRMRP AWARD MECHANISMS

Damon Runyon Fellowship Award

The Damon Runyon Cancer Research Foundation is a leading nonprofit organization that funds brave and bold cancer researchers. Damon Runyon’s mission is to identify and support the best early career scientists pursuing innovative research that has the potential to transform cancer prevention, diagnosis, and treatment. Their goal is to encourage new generations of outstanding researchers to pursue paradigm-shifting ideas and approaches as they begin highly productive, successful research careers.

Damon Runyon views cancer research very broadly, including the full spectrum of basic questions important to normal human biology and carcinogenesis, as well as development of new platforms and technologies. They encourage all theoretical and experimental research that has the potential to provide insights into cancer and the search for cancer causes, mechanisms, therapies, and prevention for all types of cancer. 

They are now accepting applications for the prestigious Damon Runyon Fellowship Award.

APPLICATION DEADLINE: August 15, 2024

The primary criteria used to evaluate applicants are:

• the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques, and clarity of presentation),

• the qualifications, experience, and productivity of both the candidate and the Sponsor,

• the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate's ability to independently conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand their scientific skill set. Direct extensions of the candidate's graduate work (in approach, technique, or exact area of study) will not be funded.

Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. 

This four-year award provides $70,000, $72,000, $74,000, and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year. The award may not be used for institutional overhead or indirect costs.

To learn more about the Foundation and the Fellowship Award review process, view the virtual Fellowship Informational Session here. 



Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award

The Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis, or treatment of one or more pediatric cancers. 

Applicants are not required to be pediatricians or members of pediatric departments; however, the proposed research must have direct relevance to one or more pediatric cancers.

Application Guidelines

APPLICATION DEADLINE: August 15, 2024

The primary criteria used to evaluate applicants are:

• potential impact of the research on pediatric cancer
• the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques, and clarity of presentation)
• the qualifications, experience, and productivity of both the candidate and the sponsor
• the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate's ability to independently conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand their scientific skill set. Direct extensions of the candidate's graduate work (in approach, technique, or exact area of study) will not be funded.

Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. 

This four-year award provides $70,000, $72,000, $74,000, and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. Damon Runyon also provides a Dependent Child Allowance of $1,000 per child per year. The award may not be used for institutional overhead or indirect costs. 

Pfizer Global Medical Grants Announces a New Education RFP in Cervical Cancer

Improving Care for Patients with Recurrent / Metastatic (R/M) Cervical Cancer

The goal of this RFP is to support education for medical oncologists, gynecologic oncologists, pharmacists, eye care providers, nurse practitioners and physician assistants working in the oncology setting caring for patients with r/m cervical cancer relating to treatments, management of adverse events, and long-term outcomes.

To review the full RFP please click here.

Application Due Date: August 22, 2024

Tony Enterante, Senior Development Officer for Corporate, Foundation and Research Relations, is happy to work with applicants on their submissions. You can contact Tony at aenteranteiii@tulane.edu.

Robert L. Fine Cancer Research Foundation Pancreatic Cancer Research Grant

Application Deadline: August 31, 2024

The Robert L. Fine Cancer Research Foundation distributes two awards every other year to outstanding young scientists dedicated to basic and translational pancreatic cancer research. The grant is intended to support research projects that can be carried out in a short period of time with limited resources. The topic of the requested grant applications will be for innovative translational pancreatic cancer research that focuses on bench to bedside advances. The grant mechanism supports different types of basic and translational projects, including pilot and feasibility studies, self-contained research projects, development of new research methodology and development of new research technology. This grant does not support solely clinical research.

The grant amount will be $250,000 to cover direct costs only. The length of the grant will be for two years payable in yearly installments. Pre-award costs are allowable, up to 30 days prior to the grant initiation date; however, the incurrence of pre-award costs imposes no obligation on the foundation to grant the award. Funding for awardees will start January 1, 2025.

For more information, click here.

Provost's Proof of Concept Fund - Fall 2024

NOW ACCEPTING APPLICATIONS

The Tulane University Innovation Institute is pleased to announce the launch of the Fall 2024 cycle of the Provost’s Proof of Concept (PPOC) Fund. This grant, up to $50,000, is designed to help advance promising ideas and technologies to become market-ready.

Members of the Tulane community (faculty, staff, graduate students, PhD students, fellows, and post-docs) with an invention disclosure filed or in preparation and an identified commercial application for the proposed technology or invention are welcome to apply.

Applications are due Friday, September 6.

Request for Proposals

Equity in Access Research Program

The Leukemia & Lymphoma Society (LLS) has just released a Request for Proposals (RFP) for its Equity in Access Research Program, which is dedicated to funding health services research.

They are reissuing the RFP Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups. Awards will be a maximum of $2.5 million each, over 5 years.

Specifically, they seek proposals that will implement and evaluate interventions designed to:

• Mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups
• Quantitatively measure the impact of these interventions on patient accrual

They are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.

It is not necessary for applicants to have previously conducted research in blood cancer. The due date for Letters of Intent is September 12, 2024 at 2 pm CST. 

For more information, please click here.

2025 Macy Faculty Scholars Program

Call for Applications

Application Deadline: September 15

The 2025 Macy Faculty Scholars Program aims to identify and nurture promising early-career educators in medicine and nursing. Macy Faculty Scholars receive up to $250,000 of salary, project, and professional development support over two years to implement an educational project in their home institutions.

Visit the website to learn more about the program and get started on your application. 

High-density resolution of the Kaposi's sarcoma associated herpesvirus transcriptome identifies novel transcript isoforms generated by long-range transcription and alternative splicing. Shekhar R, O'Grady T, Keil N, Feswick A, Amador DAM, Tibbetts SA, Flemington EK, Renne R. Nucleic Acids Res. 2024 Jul 22;52(13):7720-7739. doi: 10.1093/nar/gkae540. PMID: 38922687

Endogenous glucocorticoids are required for normal macrophage activation and gastric Helicobacter pylori immunity. Khadka S, Dziadowicz SA, Xu X, Wang L, Hu G, Carrero JA, DiPaolo RJ, Busada JT. Am J Physiol Gastrointest Liver Physiol. 2024 Jul 23. doi: 10.1152/ajpgi.00114.2024. Online ahead of print. PMID: 39041676

Valence-Change MnO₂-Coated Arsenene Nanosheets as a Pin1 Inhibitor for Hepatocellular Carcinoma Treatment. Wang J, Liang S, Zhu D, Ma X, Peng Q, Wang G, Wang Y, Chen T, Wu M, Hu TY, Zhang Y. J Am Chem Soc. 2024 Jul 25. doi: 10.1021/jacs.4c05162. Online ahead of print. PMID: 39051165

Please visit Tulane Cancer Center on Facebook, Instagram and LinkedIn and follow us for all the latest news in cancer research, education and patient care.

You can access our profile pages by clicking on the icons below.

Tulane Cancer Center now has an institutional subscription to The Cancer Letter, an independent weekly newsletter that is the leading source of information on:

• National Cancer Institute
• National Institutes of Health
• Food & Drug Administration
• the development of cancer therapies
• cancer research funding
• health care finance
• cancer legislation and policy
• clinical issues
• the pharmaceutical industry

Our institutional subscription allows anyone with a Tulane IP address to be automatically logged in when visiting www.cancerletter.com. From there you can view current and previous issues of the publication, with no need to create an individual account. 

For more information, please click here.

Acknowledging Tulane Cancer Center Support in Publications

One of the responsibilities of membership in the Tulane Cancer Center is acknowledgement of Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in presentations and publications

We suggest using the following wording when acknowledging Tulane Cancer Center support: "This work was supported by the Tulane Cancer Center, part of Tulane School of Medicine, and a consortium partner of the Louisiana Cancer Research Center."

Tulane Cancer Center Branded Assets

Tulane Cancer Center has recently undertaken a brand refresh that not only streamlines and modernizes the look and feel of our brand but also aligns us more closely with the School of Medicine branding.

With that in mind, we have developed a full suite of branded assets for your immediate use, including:

1. A Tulane Cancer Center-branded PowerPoint Slide Master
2. A Tulane Cancer Center-branded Scientific Poster Template (sized at 4 feet x 3 feet)
3. Tulane Cancer Center-branded Zoom Backgrounds
4. Tulane Cancer Center’s updated logo
5. Tulane Cancer Center-branded Email Signature Blocks

All Tulane Cancer Center Members should have received these files via a recent listserv email. If you did not receive the email but would like to begin using these templates, please contact Melanie Cross at mcross@tulane.edu.

Please also continue to acknowledgement your Tulane Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in all presentations and publications.

Thank you for your assistance in helping us to expand our visibility while showcasing the depth and breadth of our outstanding basic, translational and population science research and clinical care.  

Next Generation Sequence Analysis Core

The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.

More Information 

Cell Analysis Core

The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.

More Information

Tulane Cancer Center & LCRC Membership

Any Tulane University faculty member whose research relates to or could potentially relate to cancer – directly or indirectly – should become a member of the Tulane Cancer Center (TCC). As a member, you have access to TCC's funding opportunities, research collaboration events, and shared resources. Please click here for our membership guidelines and our online application form.

Cancer-focused faculty are also encouraged to become members of the Louisiana Cancer Research Center, a partnership between the State's foremost cancer research institutions - Tulane University School of Medicine, LSU Health Sciences Center New Orleans, Xavier University of Louisiana and Ochsner Health. Membership in the LCRC provides access to additional funding opportunities exclusively offered to LCRC members. Please click here for the LCRC's membership guidelines and online application form.

Subscribe to Nexus

If you know someone who is interested in subsribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.

Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.